Antidepressants use and risk of cataract development: a systematic review and meta-analysis

Epidemiological studies suggest that antidepressants use may increase the risk of cataract, but the results are inconclusive. We aimed to examine this association by performing a systematic review and meta-analysis. Relevant studies were identified by searching PubMed and Web of Science databases th...

Full description

Saved in:
Bibliographic Details
Published in:BMC ophthalmology 2018-02, Vol.18 (1), p.31-31, Article 31
Main Authors: Fu, Yana, Dai, Qi, Zhu, Liwei, Wu, Shuangqing
Format: Article
Language:English
Subjects:
Antidepressants
Cataract
Cataracts
Complications and side effects
Development and progression
Epidemiology
Meta-analysis
Risk
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epidemiological studies suggest that antidepressants use may increase the risk of cataract, but the results are inconclusive. We aimed to examine this association by performing a systematic review and meta-analysis. Relevant studies were identified by searching PubMed and Web of Science databases through June 2017. We included studies that reported risk estimates for the association between antidepressants use and cataract risk. A random-effects model was used to calculate the summary odds ratio (OR) with its 95% confidence interval (CI). We identified seven studies of antidepressants use and risk of cataract involving 447,672 cases and 1,510,391 controls. Overall, the combined ORs (95% CIs) of cataract for selective serotonin reuptake inhibitors (SSRIs), serotonin noradrenalin reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs) were 1.12 (1.06-1.19), 1.13 (1.04-1.24), and 1.19 (1.11-1.28), respectively. A certain degree of heterogeneity was observed across studies (P 
ISSN:1471-2415
1471-2415
DOI:10.1186/s12886-018-0699-0